Congresswoman Rosa DeLauro (CT-3) has called on Congress to go back to Washington before the November election and vote for increased funding for biomedical research. She did so at a visit to Meriden’s Protein Sciences, which is working on an Ebola vaccine.
“Biomedical research companies like Protein Sciences are helping continue Connecticut’s tradition of being a key center for innovation and high-tech manufacturing into the 21st century,” DeLauro said. “Ebola is a scary virus, but it can be contained in nations that have a strong public health infrastructure. America’s public health system is light years above most other nations’, but we must reverse the deep cuts and neglect the NIH and CDC have suffered over the past four years. This neglect vastly diminishes our ability to fight this disease—or any other. We have to be prepared and invest in the public health infrastructure that keeps America safe.”